ANIP Financial Overview

Comprehensive financial analysis and stock performance data for ANIP. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

ANIP

ANI Pharmaceuticals, Inc.

Healthcare
CEO: Nikhil Lalwani
IPO: 2000-05-05
897 employees
$88.84
0.50 (0.56%)

Market Cap

1.93B

Enterprise Value

2B

Revenue (TTM)

614.4M

Net Income

-18,522,000

P/E Ratio

-159.73x

ROE

-2.54%

Valuation Metrics
Market Cap
2B
Enterprise Value
2B
P/E Ratio
-159.73x
P/S Ratio
2.58x
P/B Ratio
4.03x
EV/Sales
2.71x
EV/FCF
18.22x
Earnings Yield
-0.63%
FCF Yield
5.78%
Price to Operating Cash Flow
12.66x
Gross Margin
57.95%
Margin Metrics
Operating Margin
2.03%
Net Margin
-1.48%
Pretax Margin
-1.97%
ROIC
0.94%
Dividends
Payout Ratio
-14.73%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
-2.54%
ROCE
1.37%
ROA
-0.82%
PEG Ratio
-3.95x
Payout Ratio
-14.73%
Financial Health
Debt to Assets
23.83%
Net Debt/EBITDA
1.08x
Growth Metrics
3Y Revenue Growth
22.84%
5Y Revenue Growth
12.76%
10Y Revenue Growth
20.05%
3Y Net Income Growth
19.73%
5Y Net Income Growth
NaN%
10Y Net Income Growth
NaN%
3Y OCF Growth
132.48%
5Y OCF Growth
-2.97%
10Y OCF Growth
5.11%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

ANIP
AugSepOctNovNovDecJanFebMarAprMayJunJulAug51.661.671.690.7
ANIP·Total: 50.86%·CAGR: 50.86%
ANI Pharmaceuticals, Inc. | Financial Overview | Monexa